VCR regimen showed efficacy in mantle cell and indolent lymphomasOctober 6, 2017Mantle Cell LymphomaIndolent Lymphoma
Copanlisib makes inroads against relapsed/refractory follicular lymphomaJuly 11, 2017Indolent Lymphoma
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017Indolent Lymphoma
Bendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Mantle Cell LymphomaIndolent Lymphoma
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphomaJune 21, 2017Indolent Lymphoma
GALEN safe and effective in relapsed and refractory follicular lymphomaJune 20, 2017Indolent Lymphoma
Waldenström macroglobulinemia panel advises on IgM paraproteinemic neuropathiesApril 19, 2017Indolent Lymphoma
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaT Cell LymphomasMantle Cell LymphomaIndolent LymphomaAggressive Lymphomas
Long view shows doubling of survival in non-Hodgkin lymphomaJanuary 30, 2017Aggressive LymphomasIndolent LymphomaHodgkin Lymphoma
